If you would like to ask our webinar guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund a question please submit them here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlobalworth Regulatory News (GWI)

Share Price Information for Globalworth (GWI)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 2.40
Bid: 2.40
Ask: 2.46
Change: -0.02 (-0.82%)
Spread: 0.06 (2.50%)
Open: 2.40
High: 2.40
Low: 2.40
Prev. Close: 2.45
GWI Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Form 8.5 (EPT/RI)- Globalworth Real Estate

15 Jun 2021 11:19

RNS Number : 9560B
JPMorgan Securities Plc
15 June 2021
 

FORM 8.5 (EPT/RI)

 

PUBLIC DEALING DISCLOSURE BY AN EXEMPT PRINCIPAL TRADER WITH RECOGNISED INTERMEDIARY STATUS DEALING IN A CLIENT-SERVING CAPACITY

Rule 8.5 of the Takeover Code (the "Code")

 

1. KEY INFORMATION

 

(a) Name of exempt principal trader:

J.P. Morgan Securities Plc

(b) Name of offeror/offeree in relation to whose relevant securities this form relates:

Use a separate form for each offeror/offeree

Globalworth Real Estate Investments Limited

(c) Name of the party to the offer with which exempt principal trader is connected:

financial advisor to Globalworth Real Estate Investments Limited

(d) Date dealing undertaken:

14 June 2021

(e) In addition to the company in 1(b) above, is the exempt principal trader making disclosures in respect of any other party to this offer?

If it is a cash offer or possible cash offer, state "N/A"

N/A

 

2. DEALINGS BY THE EXEMPT PRINCIPAL TRADER

 

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(b), copy table 2(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

 

The currency of all prices and other monetary amounts should be stated.

 

(a) Purchases and sales

 

Class of relevant security

Purchases/ sales

 

Total number of securities

Highest price per unit paid/received

Lowest price per unit paid/received

Ordinary Share

Purchase

 

Sale

6,058

 

-

7.3055 EUR

 

-

7.3000 EUR

 

-

 

(b) Cash-settled derivative transactions

 

Class of relevant security

Product description

e.g. CFD

Nature of dealing

e.g. opening/closing a long/short position, increasing/reducing a long/short position

Number of reference securities

Price per unit

Ordinary Share

Equity Swap

Increase Short

 

20

6,038

7.3000 EUR

7.3055 EUR

 

(c) Stock-settled derivative transactions (including options)

 

(i) Writing, selling, purchasing or varying

 

Class of relevant security

Product description e.g. call option

Writing, purchasing, selling, varying etc.

Number of securities to which option relates

Exercise price per unit

Type

e.g. American, European etc.

Expiry date

Option money paid/ received per unit

 

(ii) Exercise

 

Class of relevant security

Product description

e.g. call option

Exercising/ exercised against

Number of securities

Exercise price per unit

 

 

 

(d) Other dealings (including subscribing for new securities)

 

Class of relevant security

Nature of dealing

e.g. subscription, conversion

Details

Price per unit (if applicable)

 

 

 

3. OTHER INFORMATION

 

(a) Indemnity and other dealing arrangements

 

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the exempt principal trader making the disclosure and any party to the offer or any person acting in concert with a party to the offer:

Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state "none"

None

 

 

 

(b) Agreements, arrangements or understandings relating to options or derivatives

 

Details of any agreement, arrangement or understanding, formal or informal, between the exempt principal trader making the disclosure and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state "none"

None

 

 

 

Date of disclosure:

15 June 2021

Contact name:

Alwyn Basch

Telephone number:

020 7742 7407

 

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service.

 

The Panel's Market Surveillance Unit is available for consultation in relation to the Code's dealing disclosure requirements on +44 (0)20 7638 0129.

 

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
FEREAEKSFFXFEFA
Date   Source Headline
29th May 20209:30 amRNSNotice of AGM and Availability of Annual Report
28th May 20205:00 pmRNSChange of Registered Office
28th May 20204:15 pmRNSBoard Changes
18th May 20207:00 amRNSS&P and Fitch investment grade ratings maintained
15th May 20207:00 amRNSPurchase of own shares and TVR
14th May 20207:00 amRNSPurchase of own shares and TVR
11th May 202010:10 amRNSPurchase of own shares and TVR
5th May 20209:56 amRNSSatisfaction of employee share awards and TVR
28th Apr 20204:32 pmRNSMoody’s investment grade credit rating maintained
27th Apr 20204:41 pmRNSSecond Price Monitoring Extn
27th Apr 20204:36 pmRNSPrice Monitoring Extension
27th Apr 20207:00 amRNSPurchase of own shares and TVR
23rd Apr 20203:30 pmRNSBoard Changes
23rd Apr 20207:00 amRNSUpdate on Covid-19
21st Apr 20204:40 pmRNSSecond Price Monitoring Extn
21st Apr 20204:36 pmRNSPrice Monitoring Extension
30th Mar 20207:00 amRNSDirectorate Change
26th Mar 202012:28 pmRNSPosting of Annual Report and Notice of AGM
16th Mar 20202:31 pmRNSBoard Changes and COVID-19 statement
16th Mar 20201:48 pmRNSHolding(s) in Company
6th Mar 202012:00 pmRNSCondensed Unaudited Results to 31 Dec 2019
26th Feb 20206:16 pmRNSRemuneration policy, Treasury shares transfer, TVR
6th Feb 20209:36 amRNSHolding(s) in Company
5th Feb 202010:44 amRNSHolding(s) in Company
4th Feb 20207:15 amRNSHolding(s) in Company
3rd Feb 20201:25 pmRNSDirector/PDMR Shareholding
3rd Feb 202012:25 pmRNSDirector/PDMR Shareholding
3rd Feb 20208:01 amRNSHolding(s) in Company
3rd Feb 20207:30 amRNSSale by Ioannis Papalekas of Remaining Stake
27th Jan 202010:45 amRNSHolding(s) in Company
20th Jan 20202:32 pmRNSDirector/PDMR Shareholding
16th Jan 202012:05 pmRNSSecond Interim Dividend Payment
20th Dec 20197:00 amRNSFurther Acquisition in Poland
6th Dec 20194:30 pmRNSDirector/PDMR Shareholding
3rd Dec 20197:00 amRNSTransfer of shares and Director/PDMR Shareholdings
22nd Nov 20197:00 amRNSPurchase of own shares and TVR
4th Nov 20197:00 amRNSAcquisitions in Poland
1st Nov 20197:00 amRNSNew EUR 200m unsecured revolving credit facility
29th Oct 20197:00 amRNSInaugural Sustainable Development Report
16th Oct 20197:00 amRNSHolding(s) in Company
15th Oct 20191:10 pmRNSHolding(s) in Company
15th Oct 201912:30 pmRNSHolding(s) in Company
11th Oct 20197:00 amRNSResult of Placing
10th Oct 20197:00 amRNSProposed Placing
1st Oct 20197:00 amRNSIntention to Raise Additional Equity
27th Sep 20197:00 amRNSUpdate on Poland
19th Sep 20197:00 amRNSInterim Results for the six months to 30 June 2019
30th Aug 20197:00 amRNSNotice of Results & Preliminary H1 Financials
25th Jul 20197:00 amRNSHolding(s) in Company
25th Jul 20197:00 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.